Sign inLaunch App
BTC——·ETH——·GOLD——·NVDA——·SPCX——·SP500——·CC——·BTC——·ETH——·GOLD——·NVDA——·SPCX——·SP500——·CC——·
Company pair · Health
VS

BioLinq vs Kriya Therapeutics

Health Both private US-headquartered No Canborsa market

BioLinq and Kriya Therapeutics are often weighed against each other in health.

On this pageSide by sideValuation marksWhat each disclosesVerdictFAQ
BioLinqPRIVATE · US
VS
Last valuation$400M$200M
Basis Post-money Basis undisclosed
As ofApr 2025Jan 2021
Founded20102014
Employees≈118≈197
On CanborsaNo marketNo market
At a glance
$400M
BioLinqPost-money, Series C · Apr 2025
$200M
Kriya TherapeuticsSeries C · Jan 2021
A valuation basis is undisclosed — no ratio is scored
Gap
0 of 2
On CanborsaNeither company has a market
VS
Head-to-head · field by field

BioLinq vs Kriya Therapeutics — side by side

Field
BioLinqPRIVATE · FOUNDED 2010
Kriya TherapeuticsPRIVATE · FOUNDED 2014
VS
Last valuation
$400M Post-money
$200M Basis undisclosed
Valuation date
22 Apr 2025
1 Jan 2021
Latest round
Series C
Series C
Round size
$100M
$270M
Round lead
Alpha Wave Ventures
Patient Square Capital
Named investors
RiverVest Venture Partners AXA IM Alts LifeSci Venture Partners M Ventures
Novartis FMR LLC Surveyor Capital
Founded
2010
2014
Employees (est.)
≈118
≈197
Sector & HQ
Medical Devices / Biotech · 🇺🇸 US
Gene therapy and biotech · 🇺🇸 US
Status & market
Private — no Canborsa market
Private — no Canborsa market
Valuation · both companies on one scale

Valuation marks

Each bar is the last disclosed mark — $400M for BioLinq (post-money, Apr 2025) and $200M for Kriya Therapeutics (basis undisclosed, Jan 2021).

BioLinq
$400MPost-money · Apr 2025
$200Mbasis undisclosed · Jan 2021
BIOLINQ · $400M · APR 2025KRIYA THERAPEUTICS · $200M · JAN 2021
BioLinq vs Kriya Therapeutics · what each company discloses

What each company discloses, and what it leaves out

BioLinqPRIVATEHealth · US · 2010
+Last disclosed mark $400M — post-money, Apr 2025.
+Founded 2010 .
+≈118 employees.
+Latest round: Series C, $100M raised, led by Alpha Wave Ventures.
Kriya TherapeuticsPRIVATEHealth · US · 2014
+Last disclosed mark $200M — basis undisclosed, Jan 2021.
+Founded 2014 .
+≈197 employees.
+Latest round: Series C, $270M raised, led by Patient Square Capital.
+
Verdict

Verdict

The $400M tells you…
What an investor paid for newly issued shares — a primary round, priced post-money.
How much capital arrived with it:$100M, led by Alpha Wave Ventures in Apr 2025.
A dated print: it moves only when a newer round is announced.
The $200M tells you…

At least one valuation basis is undisclosed, so the two numbers stay side by side, each with its own chip, and no ratio is scored. Both are private: there is no public quote and no Canborsa market on either name.

Frequently asked questions

Are BioLinq and Kriya Therapeutics in the same sector?›

BioLinq's sector is Medical Devices / Biotech; Kriya Therapeutics' sector is Gene therapy and biotech.

How do BioLinq and Kriya Therapeutics compare in valuation?›

BioLinq is valued at $400M, and Kriya Therapeutics at $200M.

Which investors backed BioLinq and Kriya Therapeutics?›

Alpha Wave Ventures led the round for BioLinq; Patient Square Capital led for Kriya Therapeutics.

Where are BioLinq and Kriya Therapeutics based?›

BioLinq's headquarters is in San Diego, California; Kriya Therapeutics' is in Durham, North Carolina.

How old are BioLinq and Kriya Therapeutics?›

BioLinq was founded in 2010, and Kriya Therapeutics was founded in 2014.

Same pillar · company pairs

Neighbouring pairs in this sector

Calyxo vs Egenesiscompany pair · health›
$684.6Mtop valuation2.0×gap
BioLinq vs Egenesiscompany pair · health›
$400Mtop valuation1.1×gap
Calyxo vs Kriya Therapeuticscompany pair · health›
$684.6Mtop valuation3.4×gap
BioLinq vs Calyxocompany pair · health›
$684.6Mtop valuation1.7×gap
Alloy Therapeutics vs Commurecompany pair · health›
$7Btop valuation7.0×gap
Abridge vs Innovaccercompany pair · health›
$5.3Btop valuation1.5×gap
Abridge vs Neuralinkcompany pair · health›
$9Btop valuation1.7×gap
Abridge vs Alloy Therapeuticscompany pair · health›
$5.3Btop valuation5.3×gap
Keep exploring
More pairs in Health
HistoSonics vs Neuralinkcompare · versus›Benchling vs Solugencompare · versus›HistoSonics vs Zocdoccompare · versus›Benchling vs Signoscompare · versus›All company comparisonsindex›
Learn
Stock perps vs tokenized stocksconcept›RWA perpetualsmarkets · index›Perpetuals vs futuresconcept›What is a perpetual?guide · perpetuals basics›All Learn guideslearn · index›
Listed on Canborsa
SpaceX (SPCX)US equity · perp›Cerebras Systems (CBRS)US equity · perp›NVIDIA (NVDA)US equity · perp›Microsoft (MSFT)US equity · perp›All 86 marketsindex›
Company pair · Health

Trade 86 markets on Canborsa

Canborsa

Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.

Markets
Crypto perpetualsStock perpetualsGold & commoditiesIndex perpetualsAll markets ›
Companies
SpaceXOpenAIAnthropicStripeAll companies ›
Compare
Perp feesFunding ratesNo-KYC platformsCanborsa vs AvantisCanborsa vs OstiumAll comparisons ›
Learn
What is a perpetual?Funding rates explainedAirdrops & pointsAll guides ›
© Canborsa 2026TermsPrivacy